General Information of Drug Transporter (DT)
DT ID DTD0198 Transporter Info
Gene Name SLC25A36
Transporter Name Solute carrier family 25 member 36
Gene ID
55186
UniProt ID
Q96CQ1
Post-Translational Modification of This DT
Overview of SLC25A36 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

Oxidation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A36 [1]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

239

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC25A36 Cystine 239 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A36 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

61

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A36 Serine 61 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A36 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

211

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A36 Serine 211 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A36 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

219

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A36 Serine 219 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC25A36 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

236

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A36 Serine 236 has the potential to affect its expression or activity.

  Threonine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A36 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

50

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A36 Threonine 50 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A36 [3]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

238

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A36 Threonine 238 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A36 [3]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

241

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A36 Threonine 241 has the potential to affect its expression or activity.

  Tyrosine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A36 [5]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

177

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A36 Tyrosine 177 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A36 [5]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

184

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A36 Tyrosine 184 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A36 [4]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

207

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A36 Tyrosine 207 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A36 [6]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

208

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A36 Lysine 208 has the potential to affect its expression or activity.
References
1 A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
2 Fast Global Phosphoproteome Profiling of Jurkat T Cells by HIFU-TiO2-SCX-LC-MS/MS. Anal Chem. 2017 Sep 5;89(17):8853-8862.
3 Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
4 Analysis of phosphotyrosine signaling in glioblastoma identifies STAT5 as a novel downstream target of deltaEGFR. J Proteome Res. 2011 Mar 4;10(3):1343-52.
5 Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell. 2007 Dec 14;131(6):1190-203.
6 Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.